Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)

This study has been terminated.
(medical/ethical reasons)
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Technische Universität München
ClinicalTrials.gov Identifier:
NCT01528501
First received: February 1, 2012
Last updated: April 30, 2013
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)